PATEL SANJ K (Chairman & CEO) sold 48.56K shares of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC on the open market
Open‑market sale worth $2.62M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/1/2026ACC: 0001532218-26-000008
DirectorOfficer· Chairman & CEO
Since Sep 2018
-48.56K
Net shares
Net seller
$2.62M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
48.56K acquired · 97.13K disposed
Non-Derivative Transactions2
Class A Ordinary Share
Direct
Shares
+48.56K
Price / share
$30.93
Trade value
$1.50M
% of position
New position
5/1/2026
0.00→48.56K
Class A Ordinary Share
Direct
Shares
−48.56K
Price / share
$54.02
Trade value
$2.62M
% of position
New position
5/1/2026
48.56K→0.00
Total
Net shares
+0.00
Net value
-$1.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share Direct | 5/1/2026 | M · Option Exercise | +48.56K | $30.93 | $1.50M | New position | 0.00 | 48.56K |
| Class A Ordinary Share Direct | 5/1/2026 | S · Sale | −48.56K | $54.02 | $2.62M | New position | 48.56K | 0.00 |
| Total | +0.00 | -$1.12M | ||||||
Derivative Transactions1
Share Option
Direct
Converts to
Class A Ordinary Share
48.56K shares
Shares
−48.56K
Strike price
30.93
Held after
0.00
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option Direct | Class A Ordinary Share48.56K shares | 5/1/2026 | M · Option Exercise | −48.56K | 30.93 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)3
Class A Ordinary Share
IndirectShares owned76.17K
Class A Ordinary Share
IndirectShares owned51.79K
Class A Ordinary Share
IndirectShares owned109.80K
Total
237.76K indirect237.76K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Share | 76.17K | Indirect |
| Class A Ordinary Share | 51.79K | Indirect |
| Class A Ordinary Share | 109.80K | Indirect |
| Total | 237.76K | 237.76K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported